Device
Erchonia Verju Laser
Total Trials
2
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(50%)
Phase Distribution
Ph not_applicable
2
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 2 finished
Non-Completion Rate
100.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
2
all time
Status Distribution
Terminated(2)
Detailed Status
Withdrawn1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
2
Active
0
Success Rate
0.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
withdrawn150%
terminated150%
Recent Activity
0 active trials
Showing 2 of 2
terminatednot_applicable
Study of the Combined Effect of Low Level Laser Therapy and Manual Lymph Drainage on Reducing Body Circumference
NCT02591056
withdrawnnot_applicable
A Study to See if Low Level Laser Light Therapy (LLLT) Can Improve the Condition of Nonalcoholic Steatohepatitis (NASH)
NCT03163810
Clinical Trials (2)
Showing 2 of 2 trials
NCT02591056Not Applicable
Study of the Combined Effect of Low Level Laser Therapy and Manual Lymph Drainage on Reducing Body Circumference
NCT03163810Not Applicable
A Study to See if Low Level Laser Light Therapy (LLLT) Can Improve the Condition of Nonalcoholic Steatohepatitis (NASH)
All 2 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 2